List of bibliographic references
Number of relevant bibliographic references: 12.
Ident. | Authors (with country if any) | Title |
---|
000050 (2021) |
Sultan A M. Saghir [Jordanie] ; Naif A. Algabri [Yémen, Djibouti] ; Mahmoud M. Alagawany [Égypte] ; Youssef A. Attia [Égypte] ; Salem R. Alyileili [Émirats arabes unis] ; Shaaban S. Elnesr [Égypte] ; Manal E. Shafi ; Omar Y A. Al-Shargi ; Nader Al-Balagi ; Abdullah S. Alwajeeh [Qatar] ; Omar S A. Alsalahi [Yémen] ; Amlan K. Patra [Inde] ; Asmaa F. Khafaga [Égypte] ; Ahmed Negida [Royaume-Uni, Égypte] ; Ahmed Noreldin [Égypte] ; Wesam Al-Amarat [Jordanie] ; Amer A. Almaiman ; Khaled A. El-Tarabily [Émirats arabes unis, Australie] ; Mohamed E. Abd El-Hack [Égypte] | Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review. |
000083 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
000140 (2021) |
S Udhaya Kumar [Inde] ; N Madhana Priya [Inde] ; S R Nithya [Inde] ; Priyanka Kannan [Inde] ; Nikita Jain [Inde] ; D Thirumal Kumar [Inde] ; R. Magesh [Inde] ; Salma Younes [Qatar] ; Hatem Zayed [Qatar] ; C George Priya Doss [Inde] | A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. |
000243 (2021) |
Chris R. Triggle [Qatar] ; Devendra Bansal [Qatar] ; Hong Ding [Qatar] ; Md Mazharul Islam [Qatar] ; Elmoubashar Abu Baker Abd Farag [Qatar] ; Hamad Abdel Hadi [Qatar] ; Ali A. Sultan [Qatar] | A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. |
000535 (2021) |
Mohamed O. Saad [Qatar] | Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". |
000598 (2020) |
Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Sally N. Al Hassan [Liban] ; Fadi Bitar [Liban] ; Ali H. Eid [Qatar, Liban] ; Mariam Arabi [Liban] | Hydroxychloroquine in COVID-19 Patients: Pros and Cons. |
000753 (2020) |
Ali S. Omrani [Qatar] ; Sameer A. Pathan [Qatar, Royaume-Uni, Australie] ; Sarah A. Thomas [Royaume-Uni] ; Tim R E. Harris [Qatar, Royaume-Uni] ; Peter V. Coyle ; Caroline E. Thomas [Qatar] ; Isma Qureshi [Qatar] ; Zain A. Bhutta [Qatar] ; Naema Al Mawlawi ; Reham Al Kahlout ; Ashraf Elmalik [Qatar] ; Aftab M. Azad [Qatar] ; Joanne Daghfal [Qatar] ; Mulham Mustafa [Qatar] ; Andrew Jeremijenko [Qatar] ; Hussam Al Soub [Qatar] ; Mohammed Abu Khattab [Qatar] ; Muna Al Maslamani [Qatar] ; Stephen H. Thomas [Qatar, Royaume-Uni] | Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19. |
000A39 (2020) |
Junaed Younus Khan [Bangladesh] ; Md Tawkat Islam Khondaker [Bangladesh] ; Iram Tazim Hoque [Bangladesh] ; Hamada R H. Al-Absi [Qatar] ; Mohammad Saifur Rahman [Bangladesh] ; Reto Guler [Afrique du Sud] ; Tanvir Alam [Qatar] ; M Sohel Rahman [Bangladesh] | Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach. |
000C39 (2020) |
Mohammed I. Danjuma [Qatar] ; Urshita Sinha [Qatar] ; Haajra Fatima [Qatar] ; Mouhand F H. Mohamed [Qatar] ; Hendrik Nathoe [Pays-Bas] | QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor. |
001079 (2020) |
Sreethish Sasi [Qatar] ; Mohamed A. Yassin [Qatar] ; Arun Prabhakaran Nair [Qatar] ; Muna S. Al Maslamani [Qatar] | A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency. |
001431 (2020) |
Dindial Ramotar [Qatar] | The status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19. |
001434 (2020) |
Laila A. Alzaghal [Jordanie] ; Najwa Alzaghal [Qatar] ; Safwan O. Alomari [Liban] ; Nail Obeidat [Jordanie] ; Basil Obeidat [Jordanie] ; Wail A. Hayajneh [Jordanie] | Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPays.i -k "Qatar"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPays.i \
-Sk "Qatar" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Curation
|type= indexItem
|index= AffPays.i
|clé= Qatar
}}
| This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 | |